Table 1.
Uptake and adherence to treatment, and relative risk reductions for cardiovascular interventions
| Therapy/ Intervention | Percentage of uptake * | Percentage of adherence* | RRR ‡ |
|---|---|---|---|
| Antihypertensives |
87.5 |
26.3 |
0.22 |
| Lipid lowering drugs |
44.1 |
69 |
0.22 |
| Hypoglycaemic agents |
85.8 |
29.3† |
0.1 |
| Smoking cessation |
70.6 |
9.30 |
0.36 |
|
Sensitivity analyses |
|
|
|
| Antihypertensives |
57.5 |
24.8 |
0.17 |
| Lipid lowering drugs |
14.1 |
65.3 |
0.18 |
| Hypoglycaemic agents |
55.8 |
17.1 |
0.02 |
| Smoking cessation | 40.6 | 8.9 | 0.29 |
* from the NHMS III (1).
† from the diabetes registry Malaysia (13).
‡ from meta-analysis on effects on interventions on CVD events (5–8).
RRR relative risk reduction.